Gastrocnemius Stretching on Plantar Heel Pain, Foot Mobility and Function in Patients With Plantar Fasciitis
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05920551 |
Recruitment Status :
Recruiting
First Posted : June 27, 2023
Last Update Posted : June 27, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Plantar Fascitis | Other: Gastrocnemius Stretching Exercises Other: Standard care | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 60 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | Efficacy of Gastrocnemius Stretching on Plantar Heel Pain, Foot Mobility and Function in Patients With Plantar Fasciitis: A Randomised Controlled Trial |
Estimated Study Start Date : | July 1, 2023 |
Estimated Primary Completion Date : | February 1, 2024 |
Estimated Study Completion Date : | February 1, 2024 |
Arm | Intervention/treatment |
---|---|
Experimental: Gastrocnemius Stretching Group
Patients will receive ultrasound therapy, fascia strengthening exercises, and gastrocnemius stretching exercises.
|
Other: Gastrocnemius Stretching Exercises
The gastrocnemius stretching exercises will be performed by patients in the study group. These exercises will involve stretching the gastrocnemius muscle in a controlled manner to improve flexibility and reduce tension in the plantar fascia. Other: Standard care Ultrasound therapy: A therapeutic ultrasound device will be used to apply ultrasound waves to the plantar fascia area for pain relief and to promote healing. The frequency, intensity, and duration of the ultrasound therapy will be determined by the treating physical therapist based on individual patient needs.Fascia strengthening exercises: Patients will be instructed to perform exercises targeting the intrinsic foot muscles and the plantar fascia to improve strength and function. Examples of these exercises include toe curls, towel scrunches, and arch lifts. Patients will be asked to perform these exercises daily, with the specific number of repetitions and sets determined by the physical therapist. |
Active Comparator: Control Group
Patients will receive ultrasound therapy and fascia strengthening exercises without gastrocnemius stretching exercises.
|
Other: Standard care
Ultrasound therapy: A therapeutic ultrasound device will be used to apply ultrasound waves to the plantar fascia area for pain relief and to promote healing. The frequency, intensity, and duration of the ultrasound therapy will be determined by the treating physical therapist based on individual patient needs.Fascia strengthening exercises: Patients will be instructed to perform exercises targeting the intrinsic foot muscles and the plantar fascia to improve strength and function. Examples of these exercises include toe curls, towel scrunches, and arch lifts. Patients will be asked to perform these exercises daily, with the specific number of repetitions and sets determined by the physical therapist. |
- Changes in Plantar heel pain intensity [ Time Frame: Changes in Plantar heel pain intensity at Baseline and after 4 weeks of intervention and 3 months ]Measured using a Visual Analog Scale (VAS)
- Changes in Foot mobility [ Time Frame: Changes in foot mobility at Baseline and after 4 weeks of intervention and 3 months ]Measured using an inversion/eversion device
- Changes in Foot function [ Time Frame: Changes in foot function at Baseline and after 4 weeks of intervention and 3 months ]Measured using the Foot and Ankle Ability Measure (FAAM)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 30 Years to 50 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Pain reproduced with palpation of the plantar fascia
- localized and sharp but not radiating
- worse in the initial step after and an extended period of rest
- decreased initially after the first steps but exacerbated with increased activityat least 6 weeks
- unresponsive conservative form of plantar fasciitis care (ie, rest, stretching, full-length silicone insole, prescription NSAIDs when taken for a period of 2 weeks)
Exclusion Criteria:
- history of previous steroid injections
- previous surgery of the foot, lumbar spine disc herniation or back injury
- patients with rheumatic diseases (e.g., rheumatoid arthritis, spondyloarthropathy, gout disease, enthesopathy, Sjogren's syndrome, and systemic lupus erythematosus)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05920551
Contact: Mohamed M ElMeligie, Ph.d | +201064442032 | mohamed.elmeligie@acu.edu.eg |
Egypt | |
Outpatient clinic of faculty of physical therapy, Ahram Canadian University | Recruiting |
Al Ḩayy Ath Thāmin, Giza, Egypt, 3221405 | |
Contact: Mohamed M ElMeligie, Ph.d 01064442032 mohamed.elmeligie@acu.edu.eg |
Study Director: | Amal Fawzy, Ph.d | Faculty of Physical Therapy, Ahram Canadian University |
Responsible Party: | Mohamed Magdy ElMeligie, Lecturer of Physical Therapy and Director of Electromyography Lab, Ahram Canadian University |
ClinicalTrials.gov Identifier: | NCT05920551 |
Other Study ID Numbers: |
012/7080002023 |
First Posted: | June 27, 2023 Key Record Dates |
Last Update Posted: | June 27, 2023 |
Last Verified: | June 2023 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Fasciitis Fasciitis, Plantar Musculoskeletal Diseases Foot Diseases |